Fusion_HCT.zip月岛**亚弥 在2025-01-22 01:10:36 上传0 Bytes cnn fusion hyperspectral-image-classification remote-sensing transformer G. Zhao, Q. Ye, L. Sun, Z. Wu, C. Pan, and B. Jeon. "Joint Classification of Hyperspectral and LiDAR Data Using a Hierarchical CNN and Transformer," ...
In this paper, we propose a lightweight Hybrid CNN-Transformer Feature Fusion Network (dubbed as HCT-FFN) in a stage-by-stage progressive manner, which can harmonize these two architectures to help image restoration by leveraging their individual learning strengths. Specifically, we stack a ...
Donor lymphocyte infusionHematopoietic cell transplantationTyrosine kinase inhibitorTreatment for relapse of chronic myeloid leukemia (CML) following hematopoietic cell transplantation (HCT) includes tyrosine kinase inhibitors (TKI) with or without donor lymphocyte infusions (DLI), however the most effective ...
HCT116BAX-/-cells were resistant to indomethacin, but susceptibility could be recovered in cells expressing a GFP-BAX fusion protein. Titration of GFP-BAX expression revealed that the concentration of BAX required to induce a saturating apoptosis response from baseline, was rapidly achieved. Increased...
HCT116BAX-/-cells were resistant to indomethacin, but susceptibility could be recovered in cells expressing a GFP-BAX fusion protein. Titration of GFP-BAX expression revealed that the concentration of BAX required to induce a saturating apoptosis response from baseline, was rapidly achieved. Increased...
V. Infusion set, Medical grade PVC tube, with CE, ISO, GMP, BV, SGS certificates Disposable I. V. Infusion Set Components: 1. Plastic spike(with air vent/without air vent), metal spike is available 2. Drip chamber(blow moulding/injection moulding) 3. Filter inside cham...
Sahaf B, Chen G, Boiko J, Heydari K, Arai S, Miklos D. Ritux- imab Infusion after Allogeneic HCT Prevents Donor B Cell Reconsti- tution and Alloimmunity 1 Year Post Transplant. San Diego, Ca: American Society of Blood and Marrow Transplantaion; 2008....
Donor lymphocyte infusion (DLI) is a key strategy for the treatment of AML relapse after allogeneic hematopoietic cell transplantation (allo-HCT) and has been used for either prophylactic, pre-emptive, or therapeutic purposes. However, the prognosis of these patients remains dismal even after DLI ...
Donor lymphocyte infusion (DLI) is an option for relapsed hematologic malignancies or incomplete chimerism of non-malignant diseases following allogeneic hematopoietic cell transplantation (HCT). We analyzed the incidence of acute graft versus host disease (aGVHD) in patients treated with DLI. From ...
The related donor switch will be expectedly soon, and we have to wait for maturation of data both on related matched and alternative donor AHCT using post Cy infusion.Deniz Goren Sahin MDNurcan zelik BScTülay E zelik MDMutlu Arat MD